Kalvista Pharmaceuticals Inc (KALV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 04/30
| 04-2013 | 12-2012 | 04-2012 | 12-2011 | 04-2007 | |
| Cash Flows From Operating Activities | |||||
| Net Income | N/A | -2,053 | N/A | -2,050 | N/A |
| Depreciation Amortization | 20 | 38 | 30 | 30 | N/A |
| Accounts payable and accrued liabilities | N/A | -8 | N/A | N/A | N/A |
| Other Working Capital | 460 | 35 | 30 | 30 | N/A |
| Other Operating Activity | 330 | 153 | 140 | 160 | 0 |
| Operating Cash Flow | $810 | $-1,835 | $200 | $-1,830 | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -10 | -91 | -90 | -90 | N/A |
| Investing Cash Flow | $-10 | $-91 | $-90 | $-90 | $N/A |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 6,400 | 5,564 | 5,570 | 5,560 | 0 |
| Financing Cash Flow | $6,400 | $5,564 | $5,570 | $5,560 | $N/A |
| Beginning Cash Position | N/A | 4,604 | N/A | 4,600 | N/A |
| End Cash Position | N/A | 8,242 | N/A | 8,240 | N/A |
| Net Cash Flow | $7,200 | $3,638 | $5,680 | $3,630 | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | 810 | -1,835 | 200 | -1,830 | N/A |
| Capital Expenditure | N/A | -91 | N/A | N/A | N/A |
| Free Cash Flow | 810 | -1,926 | 200 | -1,830 | 0 |